10x Genomics, Inc. (LON:0A88)
London flag London · Delayed Price · Currency is GBP · Price in USD
12.58
+0.04 (0.28%)
At close: Aug 7, 2025

Endeavor Group Holdings Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
644.47610.79618.73516.41490.49298.85
Revenue Growth (YoY)
2.02%-1.28%19.81%5.28%64.13%21.54%
Cost of Revenue
196.29196209.41120.0974.0958.47
Gross Profit
448.18414.78409.31396.32416.4240.38
Selling, General & Admin
338.59343.24343.33295.8257.56202.33
Research & Development
257.91264265.73264.27211.75123.38
Operating Expenses
596.5607.24609.06560.07469.31325.7
Operating Income
-148.33-192.46-199.75-163.74-52.91-85.32
Interest Expense
-0.01-0-0.03-0.48-0.87-1.68
Interest & Investment Income
16.9518.4516.916.650.211.53
Currency Exchange Gain (Loss)
-2.1-2.11.20.2-0.91.3
Other Non Operating Income (Expenses)
6.350.520.21-0.40.10.04
EBT Excluding Unusual Items
-127.12-175.6-181.47-157.77-54.38-84.14
Merger & Restructuring Charges
----4.2--
Gain (Loss) on Sale of Investments
-0-0-1.72---
Asset Writedown
-2.1-2.1-4.6---
Legal Settlements
----0.66-1.27
Other Unusual Items
49.9-----1.52
Pretax Income
-79.33-177.7-248.76-161.97-53.72-534.48
Income Tax Expense
5.274.936.344.034.518.26
Net Income
-84.6-182.63-255.1-166-58.22-542.73
Net Income to Common
-84.6-182.63-255.1-166-58.22-542.73
Shares Outstanding (Basic)
122120117114110101
Shares Outstanding (Diluted)
122120117114110101
Shares Change (YoY)
2.95%2.80%2.90%3.18%9.09%158.76%
EPS (Basic)
-0.69-1.52-2.18-1.46-0.53-5.37
EPS (Diluted)
-0.69-1.52-2.18-1.46-0.53-5.37
Free Cash Flow
--5.73-63.8-165.27-122.65-254.56
Free Cash Flow Per Share
--0.05-0.55-1.45-1.11-2.52
Gross Margin
69.54%67.91%66.15%76.75%84.89%80.44%
Operating Margin
-23.02%-31.51%-32.28%-31.71%-10.79%-28.55%
Profit Margin
-13.13%-29.90%-41.23%-32.15%-11.87%-181.61%
Free Cash Flow Margin
--0.94%-10.31%-32.00%-25.01%-85.18%
EBITDA
-114.57-156.58-164.24-138.38-31.8-71.31
EBITDA Margin
-17.78%-25.64%-26.54%-26.80%-6.48%-23.86%
D&A For EBITDA
33.7635.8835.5125.3721.1214.01
EBIT
-148.33-192.46-199.75-163.74-52.91-85.32
EBIT Margin
-23.02%-31.51%-32.28%-31.71%-10.79%-28.55%
Advertising Expenses
-3.93.33.74.71.9
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.